Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Diabetologia. 2010 Jul 28;53(11):2312–2319. doi: 10.1007/s00125-010-1860-3

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1

Survival plots based on Cox-adjusted analysis of EDC participants stratified for the presence and severity of albuminuria, both unadjusted (a) and adjusted (b), the presence of macrovascular disease (c), and the presence of proliferative retinopathy (d) at baseline. Panels b–d are adjusted for duration of diabetes, sex, race, WHR, HbA1c, SBP, renal function (eGFR-MDRD), ever smoker, and the other complications not being presented (i.e., macrovascular disease, proliferative retinopathy, and/or renal damage). Other variables available to the model but not selected include: DBP, BP medication use, HDL and non-HDL cholesterol, and WBC count. Panel d not adjusted for renal damage status (albuminuria category)